 Connection
Jeffrey Brent to Substance-Related Disorders
This is a "connection" page, showing publications Jeffrey Brent has written about Substance-Related Disorders.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.255 |
|
|
|
-
Tebo C, Mazer-Amirshahi M, Wax P, Campleman S, Boyer E, Brent J, Sheth A, Daniuaityte R, Carlson R. Characterizing Trends in Synthetic Cannabinoid Receptor Agonist Use from Patient Clinical Evaluations during Medical Toxicology Consultation. J Psychoactive Drugs. 2021 Jul-Aug; 53(3):207-214.
Score: 0.095
-
Lee VR, Vera A, Alexander A, Ruck B, Nelson LS, Wax P, Campleman S, Brent J, Calello DP. Loperamide misuse to avoid opioid withdrawal and to achieve a euphoric effect: high doses and high risk. Clin Toxicol (Phila). 2019 03; 57(3):175-180.
Score: 0.083
-
Rhyee SH, Farrugia L, Wiegand T, Smith EA, Wax PM, Brent J. The toxicology investigators consortium case registry-the 2013 experience. J Med Toxicol. 2014 Dec; 10(4):342-59.
Score: 0.063
-
Wiegand TJ, Wax PM, Schwartz T, Finkelstein Y, Gorodetsky R, Brent J. The Toxicology Investigators Consortium Case Registry--the 2011 experience. J Med Toxicol. 2012 Dec; 8(4):360-77.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|